COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #118
Source   PDF   Share   Tweet
See all 182 studies
Early treatment study
Heras et al., Research Square, doi:10.21203/ (Preprint)
COVID-19 mortality risk factors in older people in a long-term care center
Retrospective 100 elderly nursing home patients, HC Q+AZ mortality 11.4% vs. control 61.9%, RR 0.18, p<0.001. Median age 85.
COVID-19 confirmed. 70% treated with HC Q+AZ. Details of differences between groups are not provided, and no adjustments are made. It is not clear how the groups were selected. Authors indicate treatment was early but do not specify the treatment delay.
death, ↓92.1%, p<0.001
Source   PDF   Share   Tweet
See all 182 studies
Please send us corrections, updates, or comments.